Elanco Animal Health Inc
ELAN14.065USD
+0.275+1.99%
Horário de mercado （ET）Cotações atrasadas em 15 min
6.98BValor de mercado
18.72P/L TTM
Mais detalhes de Elanco Animal Health Inc Empresa
Elanco Animal Health Incorporated is an animal health company. The Company is focused on delivering products and services to prevent and treat disease in farm animals and pets. Its diverse, durable product portfolio serves animals across many species, primarily: dogs, cats and cattle, poultry, swine, and sheep. It offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its Pet Health portfolio has products that protect pets from fleas, ticks and internal parasites. Its Farm Animal portfolio of products is primarily focused on cattle, swine, and poultry. Its Pet Health products include Advantage Family, Atopica, Claro/ Neptra, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its Farm Animal products include AviPro, Baycox, Catosal, Comforta, Denagard, Experior, Hemicell, Maxiban, Monteban, Pulmotil, Rumensin, and others.
Informações da empresa
Código da empresaELAN
Nome da EmpresaElanco Animal Health Inc
Data de listagemSep 20, 2018
CEOMr. Jeffrey N. (Jeff) Simmons
Número de funcionários9000
Tipo de títulosOrdinary Share
Fim do ano fiscalSep 20
Endereço2500 Innovation Way N
CidadeGREENFIELD
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal46140-9163
Telefone18773526261
Sitehttps://www.elanco.com/
Código da empresaELAN
Data de listagemSep 20, 2018
CEOMr. Jeffrey N. (Jeff) Simmons
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.36M
+36.70%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
205.68K
+7.83%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Chairman of the Board
Independent Chairman of the Board
150.03K
+26.80%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
99.26K
--
Mr. Art A. Garcia, CPA
Mr. Art A. Garcia, CPA
Independent Director
Independent Director
80.96K
--
Mr. Timothy J. (Tim) Bettington
Mr. Timothy J. (Tim) Bettington
Executive Vice President - Corporate Strategy and Market Development
Executive Vice President - Corporate Strategy and Market Development
80.40K
-22.66%
Dr. Deborah Turner Kochevar, Ph.D.
Dr. Deborah Turner Kochevar, Ph.D.
Independent Director
Independent Director
79.40K
--
Mr. Paul S. Herendeen
Mr. Paul S. Herendeen
Independent Director
Independent Director
74.50K
--
Mr. James Meer
Mr. James Meer
Senior Vice President, Chief Accounting Officer
Senior Vice President, Chief Accounting Officer
62.55K
-1.82%
Ms. Shiv O'Neill
Ms. Shiv O'Neill
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
53.92K
+100.82%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.36M
+36.70%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
205.68K
+7.83%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Chairman of the Board
Independent Chairman of the Board
150.03K
+26.80%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
99.26K
--
Mr. Art A. Garcia, CPA
Mr. Art A. Garcia, CPA
Independent Director
Independent Director
80.96K
--
Mr. Timothy J. (Tim) Bettington
Mr. Timothy J. (Tim) Bettington
Executive Vice President - Corporate Strategy and Market Development
Executive Vice President - Corporate Strategy and Market Development
80.40K
-22.66%
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
Pet Health
635.00M
53.23%
Farm Animal
546.00M
45.77%
Contract Manufacturing
12.00M
1.01%
Por RegiãoUSD
Nome
Receita
Proporção
International
639.00M
53.56%
United States
554.00M
46.44%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Pet Health
635.00M
53.23%
Farm Animal
546.00M
45.77%
Contract Manufacturing
12.00M
1.01%
Distribuição de ações
Atualizado em: sex, 16 de mai
Atualizado em: sex, 16 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Dodge & Cox
16.70%
PRIMECAP Management Company
10.11%
The Vanguard Group, Inc.
9.69%
Fidelity Management & Research Company LLC
7.71%
Black Creek Investment Management, Inc.
4.44%
Other
51.35%
Investidores
Investidores
Proporção
Dodge & Cox
16.70%
PRIMECAP Management Company
10.11%
The Vanguard Group, Inc.
9.69%
Fidelity Management & Research Company LLC
7.71%
Black Creek Investment Management, Inc.
4.44%
Other
51.35%
Tipos de investidores
Investidores
Proporção
Investment Advisor
63.16%
Investment Advisor/Hedge Fund
32.92%
Hedge Fund
3.35%
Individual Investor
1.08%
Research Firm
1.01%
Sovereign Wealth Fund
0.79%
Pension Fund
0.77%
Bank and Trust
0.44%
Family Office
0.11%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
879
514.22M
103.54%
-39.32M
2025Q1
974
511.32M
102.96%
-71.50M
2024Q4
996
503.77M
101.85%
-80.73M
2024Q3
1000
494.48M
100.04%
-96.31M
2024Q2
1034
494.94M
100.16%
-92.98M
2024Q1
1051
494.01M
100.22%
-99.13M
2023Q4
1048
492.96M
100.04%
-103.67M
2023Q3
1055
493.54M
100.18%
-93.98M
2023Q2
1067
490.17M
99.54%
-75.35M
2023Q1
1071
498.03M
101.25%
-46.19M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Dodge & Cox
82.92M
16.7%
-260.08K
-0.31%
Mar 31, 2025
PRIMECAP Management Company
50.22M
10.11%
-941.63K
-1.84%
Mar 31, 2025
The Vanguard Group, Inc.
48.14M
9.69%
-437.73K
-0.90%
Mar 31, 2025
Fidelity Management & Research Company LLC
38.30M
7.71%
+9.79M
+34.35%
Mar 31, 2025
Black Creek Investment Management, Inc.
22.04M
4.44%
+1.61M
+7.87%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
20.46M
4.12%
+2.56M
+14.32%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
20.06M
4.04%
-618.85K
-2.99%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
15.98M
3.22%
+292.65K
+1.87%
Mar 31, 2025
Fidelity Institutional Asset Management
15.55M
3.13%
+3.83M
+32.70%
Mar 31, 2025
Shapiro Capital Management LLC
12.33M
2.48%
-24.38K
-0.20%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 2 de ago
Atualizado em: sáb, 2 de ago
Nome
Proporção
SPDR S&P Pharmaceuticals ETF
3.83%
iShares U.S. Pharmaceuticals ETF
3.57%
First Trust Health Care Alphadex Fund
3.03%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
2.72%
First Trust NASDAQ Pharmaceuticals ETF
2.36%
Brandes US Small-Mid Cap Value ETF
2.14%
VanEck Agribusiness ETF
1.51%
First Trust Mid Cap Value AlphaDEX Fund
0.98%
Global X Adaptive US Factor ETF
0.72%
Federated Hermes MDT Large Cap Value ETF
0.7%
Ver Mais
SPDR S&P Pharmaceuticals ETF
Proporção3.83%
iShares U.S. Pharmaceuticals ETF
Proporção3.57%
First Trust Health Care Alphadex Fund
Proporção3.03%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Proporção2.72%
First Trust NASDAQ Pharmaceuticals ETF
Proporção2.36%
Brandes US Small-Mid Cap Value ETF
Proporção2.14%
VanEck Agribusiness ETF
Proporção1.51%
First Trust Mid Cap Value AlphaDEX Fund
Proporção0.98%
Global X Adaptive US Factor ETF
Proporção0.72%
Federated Hermes MDT Large Cap Value ETF
Proporção0.7%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
